Related Experiment Video
Updated: Jun 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
ON THE EXCRETION OF GLYCURONIC ACID IN PNEUMOCOCCUS INFECTIONS, WITH SPECIAL REFERENCE TO LOBAR PNEUMONIA
1Hospital of The Rockefeller Institute for Medical Research, New York.
Abstract:
1. It has been found that the amount of glycuronic acid excreted in the urine, estimated by Tollens's furfurol distillation method, is increased during the febrile period of almost all cases of lobar pneumonia in man. Patients weighing from fifty-five to seventy kilograms excrete during the febrile period 0.8 to 1.3 grams of glycuronic acid in twenty-four hours, while the output of a normal individual of the same weight, age, and under similar conditions would not exceed 0.4 to 0.6 of a gram. 2. This increased output is not dependent on outside factors; it is attributable to pathological changes of the organism itself during the disease. 3. Similar observations have been made in postpneumonic empyema and bronchopneumonia. 4. Fasting rabbits, with general pneumococcus infection, have also shown a marked increase in the output of glycuronic acid during the pathological process. Whether the conjugated substances with the glycuronic acid in the cases studied have the same origin and are qualitatively the same as under normal conditions, or whether we are dealing with different compounds, has not yet been determined.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
09:20Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: